Sponsor:
AbiliTech Medical Inc.
Code:
NCT05409079
Conditions
Muscular Dystrophies
Spinal Muscular Atrophy
Duchenne Muscular Dystrophy
Limb Girdle Muscular Dystrophy
FSHD
Eligibility Criteria
Sex: All
Age: 10+
Healthy Volunteers: Not accepted
Interventions
Abilitech Assist
Brief summary:
Conditions
Muscular Dystrophies
Spinal Muscular Atrophy
Duchenne Muscular Dystrophy
Limb Girdle Muscular Dystrophy
FSHD
Study ID
NCT05409079
Start date
May 26, 2022
Status verified date
Dec, 2022
Completion date
Jun 30, 2023
Anticipated
Primary completion date
Jun 30, 2023
Anticipated
Eligibility Criteria
Sex: All
Age: 10+
Healthy Volunteers: Not accepted
Enrollment
35 participants
Anticipated
Intervention Model
Single group
Primary purpose
Treatment
Arms
experimental: Abilitech Assist
Interventions
Abilitech Assist
Primary outcome measure
Central contacts
Locations
Gillette Children's
Recruiting
Saint Paul, Minnesota, United States, 55101
Contacts
Research
research@gillettechildrens.comSponsor
AbiliTech Medical Inc.
Last update posted
Dec 5, 2022
Last verified
Dec, 2022
Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by AbiliTech Medical Inc. on 2022-12-05.